Precision Oncology

BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
Malignant peritoneal mesothelioma (PeM) is a rare and fatal cancer originating from the abdominal lining. Our study revealed that BAP1 could serve as a prognostic and predictive biomarker for immunotherapy in PeM.
Feb 7, 2019
PDF Dataset DOI Journal PubMed Dataset2 Research Highlight
BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma
HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology
An algorithm to identify cancer driver genes in individual cancer patients by measuring the influence of gene alterations on perturbing transcriptional networks.
Jul 18, 2017
PDF Code Slides Video DOI Journal PubMed Video2 Blurb
HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology
HIT'nDRIVE: Multi-driver gene prioritization based on hitting time
Apr 1, 2014
PDF Code Video DOI Journal
HIT'nDRIVE: Multi-driver gene prioritization based on hitting time